New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Sign Up to like & getrecommendations! Published in 2021 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2020.12.013
Abstract: Elevated low-density lipoprotein cholesterol (LDL-C) is a principally modifiable cause of atherosclerotic cardiovascular disease; accordingly, recent European and US multisociety dyslipidaemia guidelines emphasise the importance of lowering LDL-C to reduce cardiovascular risk. This review provides… read more here.
Keywords: new cardiovascular; risk; dyslipidaemia; cardiovascular risk ... See more keywords
FcγRIIa: A New Cardiovascular Risk Marker.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.04.046
Abstract: Despite a consistent association between increased platelet reactivity and greater risk of cardiovascular events (CVEs), individualized antiplatelet therapy based on platelet function testing has not been effective. Intraindividual variability in platelet function over time has… read more here.
Keywords: new cardiovascular; risk; riia new; risk marker ... See more keywords